We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Dramatic Decline in Female Genital Warts Following HPV Vaccination

By HospiMedica International staff writers
Posted on 05 Jan 2015
The introduction of the Australian national human papillomavirus (HPV) vaccination program has resulted in a significant reduction of genital wart prevalence among young women.

Researchers at the University of Sydney (NSW, Australia) conducted an analysis of 1,175,879 patient encounters with 11,780 general practitioners (GPs). More...
Genital warts management rates were estimated for the periods before and after introduction of the program (pre-program, July 2002-June 2006; post-program, July 2008-June 2012). Control conditions included genital herpes and Gardnerella/bacterial vaginosis in female patients, and genital herpes and urethritis in male patients. Trends in management rates by year were also calculated.

The researchers found that the management rate of genital warts among women potentially covered by the program (i.e., ages 15–27 years) decreased by 61%, from 4.33 per 1,000 encounters in the pre-program period to 1.67 in the post-program period. Trend analysis showed a significant year-on-year reduction in the rate of genital warts management post-vaccination, and a significant increase in the management rate of control conditions per year. For all other age-sex groups there was no significant change in the management rate of genital warts between the pre- and post-program periods. The study was published in the September 2014 issue of PLOS One.

“The results show that the program has been a widespread success. Not only do genital warts cause distress in affected patients, but treatment is at a substantial cost to the health system,” said lead author Christopher Harrison, MSc, of the University of Sydney Family Medicine Research Centre (FMRC). “There was also no significant decrease in other sexually transmitted infections over this period, which means that the decrease in genital warts was likely due to the vaccination program, not a change in the women's behavior.”

Australia was one of the first countries to provide the HPV vaccine free to young women through a national immunization program. The program was initially promoted in terms of prevention of cervical cancer, as HPV types 16 and 18 are known to be the major etiological agents to cervical cancer in around 70% of cases worldwide. However, the quadrivalent vaccine also protects against HPV types 6 and 11, the major causes of genital warts.

Related Links:

University of Sydney



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Premium Air-Mattress
MA-51
Critical Care Conversion Kit
Adapter+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.